You are here: Home :: Area JESP :: Jurisprudence

Tade M Spranger

Editorial

So-called human genetic databanks (or biobanks) contain several billion tissue samples and other body substances of human origin. The debate about the appropriate rules for regulating these databanks is intensifying around the world as their number, size and scope increases, especially because of their economic relevance. As Dianne Nicol points out, there is a need for human genetic databanks to have adequate and appropriate intellectual property and access policies that provide some certainty in the rights and obligations of all parties involved. According to the author, one essential requirement for such policies is that they should explicitly make provision for benefit sharing arrangements from two distinct perspectives: general benefit to society at large; and specific benefit to the sources of the original human biological material and/or their social groupings.

Journal of International Biotechnology Law, Walter de Gruyter

Print ISSN: 1612-6068
Volume: 3, 05/2006
Pages: II - II

Show full article (external site)

Show all available items of this journal

 

Area JESP